文献速递产科麻醉

产科全身麻醉诱导药理策略的最佳实践:伞状综述

Best practice in obstetric general anaesthesia: an umbrella review of pharmacological strategies for induction of general anaesthesia.
PubMed 文献 · Anaesthesia · 2026-04-16

该伞状综述系统检索并评价剖宫产全身麻醉诱导药物的证据,纳入7项Meta分析、2项系统综述、26项随机对照试验和15项观察性研究。中等质量证据支持短效阿片类药物对母体血流动力学有益且不损害新生儿,丙泊酚为优先诱导药物,罗库溴铵≥1 mg.kg-1可作为琥珀胆碱的合适替代。

要点

  • 短效阿片类药物可改善母体血流动力学且不增加新生儿不良结局。
  • 丙泊酚早期新生儿复苏需求与硫喷妥钠相当,但母体术中知晓风险更低。
  • 罗库溴铵≥1 mg.kg-1插管条件与琥珀胆碱相当,不影响新生儿结局。

核心结论

  • 当前证据支持短效阿片类药物、丙泊酚作为优先诱导药物以及罗库溴铵作为琥珀胆碱的合适替代用于剖宫产全身麻醉诱导。

研究设计与样本

  • 伞状综述,检索Meta分析、系统综述、未综合的随机对照试验及相关观察性研究,共纳入7项Meta分析、2项系统综述、26项随机对照试验和15项观察性研究。

主要发现

  • 中等质量证据表明短效阿片类药物提供母体血流动力学益处且无新生儿不良后果。
  • 低质量证据表明丙泊酚与硫喷妥钠相比早期新生儿复苏需求相当,但母体全身麻醉期间意外知晓风险更低。
  • 拉贝洛尔、右美托咪定、利多卡因和瑞芬太尼减轻母体对喉镜置入的血流动力学反应,新生儿不良效应轻微。
  • 基于中等质量证据,罗库溴铵剂量≥1 mg.kg-1提供与琥珀胆碱相当的气管插管条件且不影响新生儿结局。

关键数值与推荐

  • 罗库溴铵剂量≥1 mg.kg-1与琥珀胆碱插管条件相当(中等质量证据)。
  • 丙泊酚早期新生儿复苏需求与硫喷妥钠相当,母体意外知晓风险更低(低质量证据)。

临床怎么用

  • 剖宫产全身麻醉诱导可优先选用丙泊酚,并考虑短效阿片类药物以维持母体血流动力学稳定。
  • 需肌松时,罗库溴铵≥1 mg.kg-1可作为琥珀胆碱的替代选择。
  • 喉镜置入前可使用拉贝洛尔、右美托咪定、利多卡因或瑞芬太尼减轻母体血流动力学反应。

局限性

  • 证据基础受限于排除高危妊娠和急诊病例,限制了普适性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: General anaesthesia for caesarean delivery carries specific maternal and neonatal risks. Drug choice, dose and timing during induction of general anaesthesia may influence maternal and neonatal physiology and outcomes. The objective of this umbrella review was to systematically identify, summarise and appraise evidence for pharmacological techniques for induction of general anaesthesia for caesarean delivery. METHODS: Databases were searched for eligible studies, including meta-analyses, systematic reviews, randomised controlled trials not previously synthesised and relevant observational studies. Data extraction, methodological quality assessment and evaluation of evidence certainty were conducted. Interventions were grouped into four categories: induction opioids; induction hypnotics; drugs to obtund the pressor response to laryngoscopy; and neuromuscular blocking drugs. RESULTS: Seven meta-analyses, two systematic reviews, 26 randomised controlled trials and 15 observational studies were included. Moderate quality evidence indicated short-acting opioids offered maternal haemodynamic benefit without negative neonatal consequences. Low quality evidence indicated propofol was associated with equivalent early neonatal resuscitation requirements compared with thiopental, but with lower risk of maternal accidental awareness during general anaesthesia. Labetalol, dexmedetomidine, lidocaine and remifentanil attenuated maternal haemodynamic response to laryngoscopy, with minimal neonatal adverse effects. Rocuronium at dose of ≥ 1 mg.kg-1 provided comparable tracheal intubation conditions to suxamethonium without affecting neonatal outcomes, based on moderate quality evidence. DISCUSSION: Current evidence supports the safety of short-acting opioids, propofol as the preferred induction drug and rocuronium as a suitable alternative to suxamethonium during induction of anaesthesia for caesarean delivery. Overall, the evidence base is constrained by exclusion of high-risk pregnancies and emergency cases, thus limiting generalisability. WHAT WE DID: We searched medical databases to find studies about the medicines used for general anaesthesia for caesarean births. We collected and checked results from different types of studies, including large reviews and clinical trials. We grouped the medicines into four types: pain medicines; anaesthetic medicines; medicines to control blood pressure and heart rate during breathing tube placement; and medicines that relax the muscles. WHY DID WE DO IT: General anaesthesia for a caesarean birth can affect both the mother and the baby. The type of medicine used, how much is given, and when it is given can change how safe and comfortable this process is. We wanted to find out which medicines work best and are safest for mothers and babies when general anaesthesia is used for a caesarean birth. WHAT WE FOUND: Short‐acting pain medicines helped keep the mother's blood pressure and heart rate more stable and did not harm the baby. The anaesthetic propofol worked as well as another older medicine for babies and reduced the chance that the mother might be aware during surgery. Several medicines helped stop large rises in blood pressure and heart rate when the breathing tube was put in, with little effect on the baby. A muscle‐relaxing medicine called rocuronium worked as well as the usual drug used for this step and did not cause problems for newborns. Overall, the evidence suggests these medicines are safe choices, but most studies did not include very high‐risk or emergency cases, so the results may not apply to everyone.

来源:Anaesthesia,查看原文。版权归原作者所有。

引用

  1. Craig R, Carnachan A, Mak KA, et al. Best practice in obstetric general anaesthesia: an umbrella review of pharmacological strategies for induction of general anaesthesia. Anaesthesia. 2026. PMID: 41987713. doi:10.1111/anae.70214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。